myotonic


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

my·o·ton·ic

(mī'ō-ton'ik),
Pertaining to or exhibiting myotonia.

myotonic

See myotonia.

my·o·ton·ic

(mī-ō-ton'ik)
Pertaining to or exhibiting myotonia.

myotonic

pertaining to or emanating from myotonia.

myotonic dimple
a depression or furrow that forms from a sudden local contraction of muscle in response to percussion and persists for up to a minute. It occurs in myotonia and is used as a diagnostic test for the condition.
myotonic myopathy
see myotonia congenita.
References in periodicals archive ?
Myotonic dystrophy--the most common adult form of muscular dystrophy--is a chronic, progressive, and inherited neuromuscular condition presenting with multisystemic complications including distal muscle weakness, myotonia, hypersomnolence, early-onset cataracts, cardiac conduction abnormalities, and slurred speech and swallowing problems (Harper, 2001).
AMO Pharma is currently advancing two investigational therapies for treatment of fragile X syndrome and myotonic dystrophy, and is in the process of licensing additional development-stage products in diverse areas including autism and other CNS disorders.
Both types of myotonic dystrophy are inherited disorders that involve progressive muscle wasting and weakness, and both are caused by a type of genetic defect known as a "RNA repeat expansion," a series of nucleotides repeated more times than normal in an individual's genetic code.
In the new study, Disney and Research Associate Lirui Guan attached a rationally designed small molecule that targets the RNA that causes myotonic dystrophy type 1 with a molecule that produces hydroxyl radicals.
Myotonic muscular dystrophy affects about 35,000 people in the U.
The use of sugammadex to reverse rocuronium in a patient with myotonic dystrophy.
Vernon was the sole carer for his wife, who suffered from the muscle-wasting disease myotonic dystrophy.
At that time, the FDA said the vast majority of the 4 million prescriptions written for quinine sulfate each year were for off-label uses, including nocturnal leg cramps, restless leg syndrome, and other myotonic disorders.
Iplex, which is already approved for treating a growth hormone deficiency, was being tested by the company as a potential treatment for myotonic muscular dystrophy (MMD), a genetic disorder that results in various symptoms across multiple body systems.
Heading this collection are short communications on considering myotonic dystrophy as a "repeat disease" and using one or two individual organisms to address population-wide genetic questions.